nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—ABCB1—epilepsy syndrome	0.0903	1	CbGaD
Dipyridamole—ABCB1—Levetiracetam—epilepsy syndrome	0.0309	0.208	CbGbCtD
Dipyridamole—ABCB1—Clobazam—epilepsy syndrome	0.0214	0.144	CbGbCtD
Dipyridamole—ABCB1—Lamotrigine—epilepsy syndrome	0.0206	0.139	CbGbCtD
Dipyridamole—ABCB1—Carbamazepine—epilepsy syndrome	0.0177	0.12	CbGbCtD
Dipyridamole—ABCB1—Phenytoin—epilepsy syndrome	0.0159	0.107	CbGbCtD
Dipyridamole—ABCB1—Phenobarbital—epilepsy syndrome	0.0142	0.0957	CbGbCtD
Dipyridamole—ABCB1—Midazolam—epilepsy syndrome	0.014	0.0944	CbGbCtD
Dipyridamole—ABCB1—Diazepam—epilepsy syndrome	0.0134	0.0907	CbGbCtD
Dipyridamole—PDE8B—forelimb—epilepsy syndrome	0.00668	0.0434	CbGeAlD
Dipyridamole—PDE10A—ganglion—epilepsy syndrome	0.00378	0.0246	CbGeAlD
Dipyridamole—PDE2A—tongue—epilepsy syndrome	0.00374	0.0243	CbGeAlD
Dipyridamole—PDE8B—ganglion—epilepsy syndrome	0.00361	0.0234	CbGeAlD
Dipyridamole—PDE1C—forebrain—epilepsy syndrome	0.00306	0.0199	CbGeAlD
Dipyridamole—PDE6B—forebrain—epilepsy syndrome	0.00262	0.017	CbGeAlD
Dipyridamole—PRUNE—telencephalon—epilepsy syndrome	0.00254	0.0165	CbGeAlD
Dipyridamole—PDE6A—head—epilepsy syndrome	0.0025	0.0162	CbGeAlD
Dipyridamole—PDE6D—telencephalon—epilepsy syndrome	0.00245	0.0159	CbGeAlD
Dipyridamole—PDE6H—forebrain—epilepsy syndrome	0.00244	0.0158	CbGeAlD
Dipyridamole—PDE6B—telencephalon—epilepsy syndrome	0.00241	0.0157	CbGeAlD
Dipyridamole—PDE1A—hindbrain—epilepsy syndrome	0.00238	0.0155	CbGeAlD
Dipyridamole—PDE6C—head—epilepsy syndrome	0.00237	0.0154	CbGeAlD
Dipyridamole—PDE1C—midbrain—epilepsy syndrome	0.00202	0.0131	CbGeAlD
Dipyridamole—PDE6B—medulla oblongata—epilepsy syndrome	0.0019	0.0123	CbGeAlD
Dipyridamole—PDE6D—midbrain—epilepsy syndrome	0.00176	0.0114	CbGeAlD
Dipyridamole—PDE1C—head—epilepsy syndrome	0.00175	0.0114	CbGeAlD
Dipyridamole—PDE6B—midbrain—epilepsy syndrome	0.00173	0.0113	CbGeAlD
Dipyridamole—PDE6B—spinal cord—epilepsy syndrome	0.00169	0.011	CbGeAlD
Dipyridamole—PDE1C—nervous system—epilepsy syndrome	0.00166	0.0108	CbGeAlD
Dipyridamole—PDE1C—central nervous system—epilepsy syndrome	0.0016	0.0104	CbGeAlD
Dipyridamole—PDE10A—forebrain—epilepsy syndrome	0.00159	0.0103	CbGeAlD
Dipyridamole—PDE2A—forebrain—epilepsy syndrome	0.00159	0.0103	CbGeAlD
Dipyridamole—PDE1B—forebrain—epilepsy syndrome	0.00157	0.0102	CbGeAlD
Dipyridamole—PDE1C—cerebellum—epilepsy syndrome	0.00156	0.0102	CbGeAlD
Dipyridamole—PDE8B—forebrain—epilepsy syndrome	0.00151	0.00983	CbGeAlD
Dipyridamole—PDE6B—head—epilepsy syndrome	0.0015	0.00976	CbGeAlD
Dipyridamole—PDE3B—forebrain—epilepsy syndrome	0.00148	0.0096	CbGeAlD
Dipyridamole—PDE2A—telencephalon—epilepsy syndrome	0.00146	0.00947	CbGeAlD
Dipyridamole—PDE10A—telencephalon—epilepsy syndrome	0.00146	0.00947	CbGeAlD
Dipyridamole—PDE1B—telencephalon—epilepsy syndrome	0.00145	0.00939	CbGeAlD
Dipyridamole—PDE6B—nervous system—epilepsy syndrome	0.00142	0.00925	CbGeAlD
Dipyridamole—PRUNE—cerebellum—epilepsy syndrome	0.00141	0.00916	CbGeAlD
Dipyridamole—PDE6H—head—epilepsy syndrome	0.0014	0.00907	CbGeAlD
Dipyridamole—PDE8B—telencephalon—epilepsy syndrome	0.00139	0.00904	CbGeAlD
Dipyridamole—PDE6B—central nervous system—epilepsy syndrome	0.00137	0.00891	CbGeAlD
Dipyridamole—PDE1A—brainstem—epilepsy syndrome	0.00136	0.00886	CbGeAlD
Dipyridamole—PDE6D—cerebellum—epilepsy syndrome	0.00136	0.00885	CbGeAlD
Dipyridamole—PDE6G—head—epilepsy syndrome	0.00134	0.00873	CbGeAlD
Dipyridamole—PDE6B—cerebellum—epilepsy syndrome	0.00134	0.0087	CbGeAlD
Dipyridamole—PDE6H—nervous system—epilepsy syndrome	0.00132	0.0086	CbGeAlD
Dipyridamole—PDE1A—forebrain—epilepsy syndrome	0.00132	0.00855	CbGeAlD
Dipyridamole—PDE6H—central nervous system—epilepsy syndrome	0.00128	0.00828	CbGeAlD
Dipyridamole—PDE1C—brain—epilepsy syndrome	0.00127	0.00825	CbGeAlD
Dipyridamole—PDE8A—telencephalon—epilepsy syndrome	0.00125	0.00813	CbGeAlD
Dipyridamole—PDE7A—head—epilepsy syndrome	0.00125	0.00808	CbGeAlD
Dipyridamole—PDE1A—telencephalon—epilepsy syndrome	0.00121	0.00787	CbGeAlD
Dipyridamole—PDE7A—nervous system—epilepsy syndrome	0.00118	0.00766	CbGeAlD
Dipyridamole—PDE2A—medulla oblongata—epilepsy syndrome	0.00115	0.00744	CbGeAlD
Dipyridamole—PRUNE—brain—epilepsy syndrome	0.00115	0.00744	CbGeAlD
Dipyridamole—PDE7A—central nervous system—epilepsy syndrome	0.00114	0.00738	CbGeAlD
Dipyridamole—PDE6D—brain—epilepsy syndrome	0.00111	0.00719	CbGeAlD
Dipyridamole—PDE6B—brain—epilepsy syndrome	0.00109	0.00707	CbGeAlD
Dipyridamole—PDE7B—head—epilepsy syndrome	0.00109	0.00707	CbGeAlD
Dipyridamole—PDE2A—midbrain—epilepsy syndrome	0.00105	0.0068	CbGeAlD
Dipyridamole—PDE7B—nervous system—epilepsy syndrome	0.00103	0.0067	CbGeAlD
Dipyridamole—PDE2A—spinal cord—epilepsy syndrome	0.00102	0.00664	CbGeAlD
Dipyridamole—PDE6H—brain—epilepsy syndrome	0.00101	0.00657	CbGeAlD
Dipyridamole—PDE11A—brain—epilepsy syndrome	0.00101	0.00657	CbGeAlD
Dipyridamole—PDE4A—telencephalon—epilepsy syndrome	0.001	0.00652	CbGeAlD
Dipyridamole—PDE8B—midbrain—epilepsy syndrome	0.000999	0.00649	CbGeAlD
Dipyridamole—PDE7B—central nervous system—epilepsy syndrome	0.000993	0.00645	CbGeAlD
Dipyridamole—PDE8A—medulla oblongata—epilepsy syndrome	0.000983	0.00639	CbGeAlD
Dipyridamole—PDE1A—medulla oblongata—epilepsy syndrome	0.000952	0.00618	CbGeAlD
Dipyridamole—PDE5A—forebrain—epilepsy syndrome	0.000928	0.00603	CbGeAlD
Dipyridamole—PDE10A—head—epilepsy syndrome	0.000908	0.0059	CbGeAlD
Dipyridamole—PDE2A—head—epilepsy syndrome	0.000908	0.0059	CbGeAlD
Dipyridamole—PDE7A—brain—epilepsy syndrome	0.000902	0.00586	CbGeAlD
Dipyridamole—PDE1B—head—epilepsy syndrome	0.0009	0.00585	CbGeAlD
Dipyridamole—PDE8A—midbrain—epilepsy syndrome	0.000899	0.00584	CbGeAlD
Dipyridamole—PDE8A—spinal cord—epilepsy syndrome	0.000877	0.00569	CbGeAlD
Dipyridamole—PDE1A—midbrain—epilepsy syndrome	0.00087	0.00565	CbGeAlD
Dipyridamole—PDE8B—head—epilepsy syndrome	0.000866	0.00563	CbGeAlD
Dipyridamole—PDE2A—nervous system—epilepsy syndrome	0.000861	0.00559	CbGeAlD
Dipyridamole—PDE10A—nervous system—epilepsy syndrome	0.000861	0.00559	CbGeAlD
Dipyridamole—PDE5A—telencephalon—epilepsy syndrome	0.000853	0.00554	CbGeAlD
Dipyridamole—PDE1B—nervous system—epilepsy syndrome	0.000853	0.00554	CbGeAlD
Dipyridamole—PDE1A—spinal cord—epilepsy syndrome	0.000849	0.00551	CbGeAlD
Dipyridamole—PDE2A—central nervous system—epilepsy syndrome	0.000829	0.00538	CbGeAlD
Dipyridamole—PDE10A—central nervous system—epilepsy syndrome	0.000829	0.00538	CbGeAlD
Dipyridamole—PDE1B—central nervous system—epilepsy syndrome	0.000822	0.00534	CbGeAlD
Dipyridamole—PDE8B—nervous system—epilepsy syndrome	0.000821	0.00533	CbGeAlD
Dipyridamole—PDE2A—cerebellum—epilepsy syndrome	0.00081	0.00526	CbGeAlD
Dipyridamole—PDE10A—cerebellum—epilepsy syndrome	0.00081	0.00526	CbGeAlD
Dipyridamole—PDE1B—cerebellum—epilepsy syndrome	0.000803	0.00521	CbGeAlD
Dipyridamole—PDE8B—central nervous system—epilepsy syndrome	0.000791	0.00514	CbGeAlD
Dipyridamole—PDE7B—brain—epilepsy syndrome	0.000789	0.00512	CbGeAlD
Dipyridamole—ABCC5—telencephalon—epilepsy syndrome	0.000781	0.00507	CbGeAlD
Dipyridamole—SLC29A1—forebrain—epilepsy syndrome	0.000779	0.00506	CbGeAlD
Dipyridamole—PDE8B—cerebellum—epilepsy syndrome	0.000773	0.00502	CbGeAlD
Dipyridamole—PDE3B—cerebellum—epilepsy syndrome	0.000755	0.0049	CbGeAlD
Dipyridamole—PDE1A—head—epilepsy syndrome	0.000754	0.0049	CbGeAlD
Dipyridamole—SLC29A1—telencephalon—epilepsy syndrome	0.000717	0.00465	CbGeAlD
Dipyridamole—PDE1A—nervous system—epilepsy syndrome	0.000715	0.00464	CbGeAlD
Dipyridamole—PDE8A—cerebellum—epilepsy syndrome	0.000695	0.00452	CbGeAlD
Dipyridamole—PDE1A—central nervous system—epilepsy syndrome	0.000689	0.00447	CbGeAlD
Dipyridamole—PDE1A—cerebellum—epilepsy syndrome	0.000673	0.00437	CbGeAlD
Dipyridamole—PDE2A—brain—epilepsy syndrome	0.000658	0.00427	CbGeAlD
Dipyridamole—PDE10A—brain—epilepsy syndrome	0.000658	0.00427	CbGeAlD
Dipyridamole—PDE1B—brain—epilepsy syndrome	0.000652	0.00424	CbGeAlD
Dipyridamole—ADA—head—epilepsy syndrome	0.000641	0.00416	CbGeAlD
Dipyridamole—PDE8B—brain—epilepsy syndrome	0.000628	0.00408	CbGeAlD
Dipyridamole—ABCC5—medulla oblongata—epilepsy syndrome	0.000613	0.00398	CbGeAlD
Dipyridamole—PDE3B—brain—epilepsy syndrome	0.000613	0.00398	CbGeAlD
Dipyridamole—ADA—nervous system—epilepsy syndrome	0.000608	0.00395	CbGeAlD
Dipyridamole—ABCC4—forebrain—epilepsy syndrome	0.000588	0.00382	CbGeAlD
Dipyridamole—ADA—central nervous system—epilepsy syndrome	0.000585	0.0038	CbGeAlD
Dipyridamole—PDE8A—brain—epilepsy syndrome	0.000565	0.00367	CbGeAlD
Dipyridamole—ABCC5—midbrain—epilepsy syndrome	0.000561	0.00364	CbGeAlD
Dipyridamole—PDE4A—cerebellum—epilepsy syndrome	0.000558	0.00362	CbGeAlD
Dipyridamole—PDE1A—brain—epilepsy syndrome	0.000547	0.00355	CbGeAlD
Dipyridamole—PDE5A—head—epilepsy syndrome	0.000531	0.00345	CbGeAlD
Dipyridamole—PDE5A—nervous system—epilepsy syndrome	0.000504	0.00327	CbGeAlD
Dipyridamole—PDE5A—central nervous system—epilepsy syndrome	0.000485	0.00315	CbGeAlD
Dipyridamole—PDE5A—cerebellum—epilepsy syndrome	0.000474	0.00308	CbGeAlD
Dipyridamole—ADA—brain—epilepsy syndrome	0.000465	0.00302	CbGeAlD
Dipyridamole—PDE3A—cerebellum—epilepsy syndrome	0.000461	0.003	CbGeAlD
Dipyridamole—PDE4A—brain—epilepsy syndrome	0.000453	0.00294	CbGeAlD
Dipyridamole—SLC29A1—head—epilepsy syndrome	0.000446	0.0029	CbGeAlD
Dipyridamole—ABCC5—cerebellum—epilepsy syndrome	0.000434	0.00282	CbGeAlD
Dipyridamole—SLC29A1—nervous system—epilepsy syndrome	0.000423	0.00275	CbGeAlD
Dipyridamole—SLC29A1—central nervous system—epilepsy syndrome	0.000407	0.00265	CbGeAlD
Dipyridamole—SLC29A1—cerebellum—epilepsy syndrome	0.000398	0.00259	CbGeAlD
Dipyridamole—PDE5A—brain—epilepsy syndrome	0.000385	0.0025	CbGeAlD
Dipyridamole—PDE3A—brain—epilepsy syndrome	0.000375	0.00243	CbGeAlD
Dipyridamole—ABCC5—brain—epilepsy syndrome	0.000352	0.00229	CbGeAlD
Dipyridamole—ABCC4—head—epilepsy syndrome	0.000337	0.00219	CbGeAlD
Dipyridamole—SLC29A1—brain—epilepsy syndrome	0.000323	0.0021	CbGeAlD
Dipyridamole—ABCC4—nervous system—epilepsy syndrome	0.000319	0.00207	CbGeAlD
Dipyridamole—ABCC4—central nervous system—epilepsy syndrome	0.000308	0.002	CbGeAlD
Dipyridamole—ABCC4—brain—epilepsy syndrome	0.000244	0.00159	CbGeAlD
Dipyridamole—ABCB1—forebrain—epilepsy syndrome	0.000205	0.00133	CbGeAlD
Dipyridamole—ABCB1—telencephalon—epilepsy syndrome	0.000188	0.00122	CbGeAlD
Dipyridamole—ABCB1—medulla oblongata—epilepsy syndrome	0.000148	0.000961	CbGeAlD
Dipyridamole—ABCB1—midbrain—epilepsy syndrome	0.000135	0.000878	CbGeAlD
Dipyridamole—ABCB1—spinal cord—epilepsy syndrome	0.000132	0.000857	CbGeAlD
Dipyridamole—ABCB1—head—epilepsy syndrome	0.000117	0.000762	CbGeAlD
Dipyridamole—Tachycardia—Valproic Acid—epilepsy syndrome	0.000112	0.000321	CcSEcCtD
Dipyridamole—Diarrhoea—Zonisamide—epilepsy syndrome	0.000112	0.000321	CcSEcCtD
Dipyridamole—Pharyngitis—Topiramate—epilepsy syndrome	0.000112	0.000321	CcSEcCtD
Dipyridamole—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000112	0.00032	CcSEcCtD
Dipyridamole—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000112	0.00032	CcSEcCtD
Dipyridamole—Pruritus—Clonazepam—epilepsy syndrome	0.000112	0.00032	CcSEcCtD
Dipyridamole—Vomiting—Vigabatrin—epilepsy syndrome	0.000112	0.00032	CcSEcCtD
Dipyridamole—Skin disorder—Valproic Acid—epilepsy syndrome	0.000112	0.00032	CcSEcCtD
Dipyridamole—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000111	0.000318	CcSEcCtD
Dipyridamole—Cough—Pregabalin—epilepsy syndrome	0.000111	0.000318	CcSEcCtD
Dipyridamole—ABCB1—nervous system—epilepsy syndrome	0.000111	0.000722	CbGeAlD
Dipyridamole—Pruritus—Phenytoin—epilepsy syndrome	0.000111	0.000318	CcSEcCtD
Dipyridamole—Nausea—Levetiracetam—epilepsy syndrome	0.000111	0.000317	CcSEcCtD
Dipyridamole—Rash—Vigabatrin—epilepsy syndrome	0.000111	0.000317	CcSEcCtD
Dipyridamole—Dizziness—Felbamate—epilepsy syndrome	0.000111	0.000317	CcSEcCtD
Dipyridamole—Dermatitis—Vigabatrin—epilepsy syndrome	0.000111	0.000317	CcSEcCtD
Dipyridamole—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000111	0.000316	CcSEcCtD
Dipyridamole—Convulsion—Pregabalin—epilepsy syndrome	0.000111	0.000316	CcSEcCtD
Dipyridamole—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.00011	0.000316	CcSEcCtD
Dipyridamole—Headache—Vigabatrin—epilepsy syndrome	0.00011	0.000315	CcSEcCtD
Dipyridamole—Hypertension—Pregabalin—epilepsy syndrome	0.00011	0.000315	CcSEcCtD
Dipyridamole—Vomiting—Diazepam—epilepsy syndrome	0.00011	0.000315	CcSEcCtD
Dipyridamole—Tremor—Gabapentin—epilepsy syndrome	0.00011	0.000313	CcSEcCtD
Dipyridamole—Rash—Diazepam—epilepsy syndrome	0.000109	0.000312	CcSEcCtD
Dipyridamole—Dermatitis—Diazepam—epilepsy syndrome	0.000109	0.000312	CcSEcCtD
Dipyridamole—Chest pain—Pregabalin—epilepsy syndrome	0.000109	0.00031	CcSEcCtD
Dipyridamole—Arthralgia—Pregabalin—epilepsy syndrome	0.000109	0.00031	CcSEcCtD
Dipyridamole—Myalgia—Pregabalin—epilepsy syndrome	0.000109	0.00031	CcSEcCtD
Dipyridamole—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.000109	0.00031	CcSEcCtD
Dipyridamole—Dizziness—Zonisamide—epilepsy syndrome	0.000109	0.00031	CcSEcCtD
Dipyridamole—Headache—Diazepam—epilepsy syndrome	0.000108	0.00031	CcSEcCtD
Dipyridamole—Anxiety—Pregabalin—epilepsy syndrome	0.000108	0.000309	CcSEcCtD
Dipyridamole—Diarrhoea—Clonazepam—epilepsy syndrome	0.000108	0.000309	CcSEcCtD
Dipyridamole—Anaemia—Gabapentin—epilepsy syndrome	0.000108	0.000309	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000108	0.000308	CcSEcCtD
Dipyridamole—Hypotension—Valproic Acid—epilepsy syndrome	0.000108	0.000307	CcSEcCtD
Dipyridamole—Asthenia—Carbamazepine—epilepsy syndrome	0.000108	0.000307	CcSEcCtD
Dipyridamole—Diarrhoea—Phenytoin—epilepsy syndrome	0.000107	0.000307	CcSEcCtD
Dipyridamole—Discomfort—Pregabalin—epilepsy syndrome	0.000107	0.000307	CcSEcCtD
Dipyridamole—Nausea—Fosphenytoin—epilepsy syndrome	0.000107	0.000306	CcSEcCtD
Dipyridamole—ABCB1—central nervous system—epilepsy syndrome	0.000107	0.000695	CbGeAlD
Dipyridamole—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000107	0.000305	CcSEcCtD
Dipyridamole—Angioedema—Gabapentin—epilepsy syndrome	0.000107	0.000305	CcSEcCtD
Dipyridamole—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000107	0.000305	CcSEcCtD
Dipyridamole—Vomiting—Felbamate—epilepsy syndrome	0.000107	0.000305	CcSEcCtD
Dipyridamole—Dry mouth—Pregabalin—epilepsy syndrome	0.000106	0.000303	CcSEcCtD
Dipyridamole—Pruritus—Carbamazepine—epilepsy syndrome	0.000106	0.000303	CcSEcCtD
Dipyridamole—Rash—Felbamate—epilepsy syndrome	0.000106	0.000302	CcSEcCtD
Dipyridamole—Dermatitis—Felbamate—epilepsy syndrome	0.000106	0.000302	CcSEcCtD
Dipyridamole—Malaise—Gabapentin—epilepsy syndrome	0.000105	0.000301	CcSEcCtD
Dipyridamole—Tinnitus—Topiramate—epilepsy syndrome	0.000105	0.000301	CcSEcCtD
Dipyridamole—Vertigo—Gabapentin—epilepsy syndrome	0.000105	0.0003	CcSEcCtD
Dipyridamole—Headache—Felbamate—epilepsy syndrome	0.000105	0.0003	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000105	0.0003	CcSEcCtD
Dipyridamole—Flushing—Topiramate—epilepsy syndrome	0.000105	0.0003	CcSEcCtD
Dipyridamole—Cardiac disorder—Topiramate—epilepsy syndrome	0.000105	0.0003	CcSEcCtD
Dipyridamole—Syncope—Gabapentin—epilepsy syndrome	0.000105	0.0003	CcSEcCtD
Dipyridamole—ABCB1—cerebellum—epilepsy syndrome	0.000105	0.000679	CbGeAlD
Dipyridamole—Dizziness—Clonazepam—epilepsy syndrome	0.000105	0.000299	CcSEcCtD
Dipyridamole—Nausea—Vigabatrin—epilepsy syndrome	0.000104	0.000299	CcSEcCtD
Dipyridamole—Vomiting—Zonisamide—epilepsy syndrome	0.000104	0.000298	CcSEcCtD
Dipyridamole—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000104	0.000297	CcSEcCtD
Dipyridamole—Oedema—Pregabalin—epilepsy syndrome	0.000104	0.000297	CcSEcCtD
Dipyridamole—Asthenia—Lamotrigine—epilepsy syndrome	0.000104	0.000297	CcSEcCtD
Dipyridamole—Dizziness—Phenytoin—epilepsy syndrome	0.000104	0.000297	CcSEcCtD
Dipyridamole—Rash—Zonisamide—epilepsy syndrome	0.000103	0.000296	CcSEcCtD
Dipyridamole—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000103	0.000295	CcSEcCtD
Dipyridamole—Palpitations—Gabapentin—epilepsy syndrome	0.000103	0.000295	CcSEcCtD
Dipyridamole—Dermatitis—Zonisamide—epilepsy syndrome	0.000103	0.000295	CcSEcCtD
Dipyridamole—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000103	0.000295	CcSEcCtD
Dipyridamole—Nausea—Diazepam—epilepsy syndrome	0.000103	0.000294	CcSEcCtD
Dipyridamole—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000103	0.000294	CcSEcCtD
Dipyridamole—Headache—Zonisamide—epilepsy syndrome	0.000103	0.000294	CcSEcCtD
Dipyridamole—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000103	0.000293	CcSEcCtD
Dipyridamole—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000103	0.000293	CcSEcCtD
Dipyridamole—Angiopathy—Topiramate—epilepsy syndrome	0.000103	0.000293	CcSEcCtD
Dipyridamole—Pruritus—Lamotrigine—epilepsy syndrome	0.000103	0.000293	CcSEcCtD
Dipyridamole—Shock—Pregabalin—epilepsy syndrome	0.000102	0.000293	CcSEcCtD
Dipyridamole—Somnolence—Valproic Acid—epilepsy syndrome	0.000102	0.000293	CcSEcCtD
Dipyridamole—Immune system disorder—Topiramate—epilepsy syndrome	0.000102	0.000292	CcSEcCtD
Dipyridamole—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000102	0.000292	CcSEcCtD
Dipyridamole—Cough—Gabapentin—epilepsy syndrome	0.000102	0.000292	CcSEcCtD
Dipyridamole—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000102	0.000291	CcSEcCtD
Dipyridamole—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000102	0.000291	CcSEcCtD
Dipyridamole—Tachycardia—Pregabalin—epilepsy syndrome	0.000102	0.00029	CcSEcCtD
Dipyridamole—Chills—Topiramate—epilepsy syndrome	0.000101	0.00029	CcSEcCtD
Dipyridamole—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000101	0.00029	CcSEcCtD
Dipyridamole—Convulsion—Gabapentin—epilepsy syndrome	0.000101	0.00029	CcSEcCtD
Dipyridamole—Skin disorder—Pregabalin—epilepsy syndrome	0.000101	0.000289	CcSEcCtD
Dipyridamole—Hypertension—Gabapentin—epilepsy syndrome	0.000101	0.000289	CcSEcCtD
Dipyridamole—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000101	0.000288	CcSEcCtD
Dipyridamole—Vomiting—Clonazepam—epilepsy syndrome	0.000101	0.000287	CcSEcCtD
Dipyridamole—Alopecia—Topiramate—epilepsy syndrome	9.99e-05	0.000285	CcSEcCtD
Dipyridamole—Vomiting—Phenytoin—epilepsy syndrome	9.99e-05	0.000285	CcSEcCtD
Dipyridamole—Rash—Clonazepam—epilepsy syndrome	9.97e-05	0.000285	CcSEcCtD
Dipyridamole—Dermatitis—Clonazepam—epilepsy syndrome	9.96e-05	0.000285	CcSEcCtD
Dipyridamole—Arthralgia—Gabapentin—epilepsy syndrome	9.96e-05	0.000285	CcSEcCtD
Dipyridamole—Chest pain—Gabapentin—epilepsy syndrome	9.96e-05	0.000285	CcSEcCtD
Dipyridamole—Myalgia—Gabapentin—epilepsy syndrome	9.96e-05	0.000285	CcSEcCtD
Dipyridamole—Nausea—Felbamate—epilepsy syndrome	9.96e-05	0.000285	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	9.94e-05	0.000284	CcSEcCtD
Dipyridamole—Vomiting—Oxcarbazepine—epilepsy syndrome	9.93e-05	0.000284	CcSEcCtD
Dipyridamole—Fatigue—Valproic Acid—epilepsy syndrome	9.93e-05	0.000284	CcSEcCtD
Dipyridamole—Anxiety—Gabapentin—epilepsy syndrome	9.92e-05	0.000284	CcSEcCtD
Dipyridamole—Dizziness—Carbamazepine—epilepsy syndrome	9.91e-05	0.000283	CcSEcCtD
Dipyridamole—Diarrhoea—Lamotrigine—epilepsy syndrome	9.91e-05	0.000283	CcSEcCtD
Dipyridamole—Headache—Clonazepam—epilepsy syndrome	9.91e-05	0.000283	CcSEcCtD
Dipyridamole—Rash—Phenytoin—epilepsy syndrome	9.9e-05	0.000283	CcSEcCtD
Dipyridamole—Dermatitis—Phenytoin—epilepsy syndrome	9.89e-05	0.000283	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	9.89e-05	0.000283	CcSEcCtD
Dipyridamole—Rash—Oxcarbazepine—epilepsy syndrome	9.85e-05	0.000282	CcSEcCtD
Dipyridamole—Pain—Valproic Acid—epilepsy syndrome	9.85e-05	0.000281	CcSEcCtD
Dipyridamole—Dermatitis—Oxcarbazepine—epilepsy syndrome	9.84e-05	0.000281	CcSEcCtD
Dipyridamole—Headache—Phenytoin—epilepsy syndrome	9.84e-05	0.000281	CcSEcCtD
Dipyridamole—Discomfort—Gabapentin—epilepsy syndrome	9.84e-05	0.000281	CcSEcCtD
Dipyridamole—Headache—Oxcarbazepine—epilepsy syndrome	9.79e-05	0.00028	CcSEcCtD
Dipyridamole—Nausea—Zonisamide—epilepsy syndrome	9.75e-05	0.000279	CcSEcCtD
Dipyridamole—Dry mouth—Gabapentin—epilepsy syndrome	9.74e-05	0.000278	CcSEcCtD
Dipyridamole—Hypotension—Pregabalin—epilepsy syndrome	9.73e-05	0.000278	CcSEcCtD
Dipyridamole—Flatulence—Topiramate—epilepsy syndrome	9.7e-05	0.000277	CcSEcCtD
Dipyridamole—Tension—Topiramate—epilepsy syndrome	9.66e-05	0.000276	CcSEcCtD
Dipyridamole—Dysgeusia—Topiramate—epilepsy syndrome	9.64e-05	0.000275	CcSEcCtD
Dipyridamole—Dizziness—Lamotrigine—epilepsy syndrome	9.58e-05	0.000274	CcSEcCtD
Dipyridamole—Nervousness—Topiramate—epilepsy syndrome	9.56e-05	0.000273	CcSEcCtD
Dipyridamole—Anaphylactic shock—Gabapentin—epilepsy syndrome	9.55e-05	0.000273	CcSEcCtD
Dipyridamole—Oedema—Gabapentin—epilepsy syndrome	9.55e-05	0.000273	CcSEcCtD
Dipyridamole—Vomiting—Carbamazepine—epilepsy syndrome	9.53e-05	0.000272	CcSEcCtD
Dipyridamole—Back pain—Topiramate—epilepsy syndrome	9.52e-05	0.000272	CcSEcCtD
Dipyridamole—Feeling abnormal—Valproic Acid—epilepsy syndrome	9.49e-05	0.000271	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	9.48e-05	0.000271	CcSEcCtD
Dipyridamole—Muscle spasms—Topiramate—epilepsy syndrome	9.46e-05	0.00027	CcSEcCtD
Dipyridamole—Rash—Carbamazepine—epilepsy syndrome	9.45e-05	0.00027	CcSEcCtD
Dipyridamole—Dermatitis—Carbamazepine—epilepsy syndrome	9.45e-05	0.00027	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	9.42e-05	0.000269	CcSEcCtD
Dipyridamole—Nausea—Clonazepam—epilepsy syndrome	9.39e-05	0.000268	CcSEcCtD
Dipyridamole—Headache—Carbamazepine—epilepsy syndrome	9.39e-05	0.000268	CcSEcCtD
Dipyridamole—Shock—Gabapentin—epilepsy syndrome	9.39e-05	0.000268	CcSEcCtD
Dipyridamole—Nervous system disorder—Gabapentin—epilepsy syndrome	9.36e-05	0.000268	CcSEcCtD
Dipyridamole—Paraesthesia—Pregabalin—epilepsy syndrome	9.35e-05	0.000267	CcSEcCtD
Dipyridamole—Thrombocytopenia—Gabapentin—epilepsy syndrome	9.35e-05	0.000267	CcSEcCtD
Dipyridamole—Nausea—Phenytoin—epilepsy syndrome	9.33e-05	0.000267	CcSEcCtD
Dipyridamole—Tachycardia—Gabapentin—epilepsy syndrome	9.32e-05	0.000266	CcSEcCtD
Dipyridamole—Dyspnoea—Pregabalin—epilepsy syndrome	9.28e-05	0.000265	CcSEcCtD
Dipyridamole—Nausea—Oxcarbazepine—epilepsy syndrome	9.28e-05	0.000265	CcSEcCtD
Dipyridamole—Skin disorder—Gabapentin—epilepsy syndrome	9.27e-05	0.000265	CcSEcCtD
Dipyridamole—Somnolence—Pregabalin—epilepsy syndrome	9.25e-05	0.000264	CcSEcCtD
Dipyridamole—Hyperhidrosis—Gabapentin—epilepsy syndrome	9.23e-05	0.000264	CcSEcCtD
Dipyridamole—Tremor—Topiramate—epilepsy syndrome	9.22e-05	0.000263	CcSEcCtD
Dipyridamole—Vomiting—Lamotrigine—epilepsy syndrome	9.21e-05	0.000263	CcSEcCtD
Dipyridamole—Urticaria—Valproic Acid—epilepsy syndrome	9.15e-05	0.000261	CcSEcCtD
Dipyridamole—Rash—Lamotrigine—epilepsy syndrome	9.14e-05	0.000261	CcSEcCtD
Dipyridamole—Ill-defined disorder—Topiramate—epilepsy syndrome	9.13e-05	0.000261	CcSEcCtD
Dipyridamole—Dermatitis—Lamotrigine—epilepsy syndrome	9.13e-05	0.000261	CcSEcCtD
Dipyridamole—Abdominal pain—Valproic Acid—epilepsy syndrome	9.1e-05	0.00026	CcSEcCtD
Dipyridamole—Anaemia—Topiramate—epilepsy syndrome	9.1e-05	0.00026	CcSEcCtD
Dipyridamole—Headache—Lamotrigine—epilepsy syndrome	9.08e-05	0.000259	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	8.99e-05	0.000257	CcSEcCtD
Dipyridamole—Fatigue—Pregabalin—epilepsy syndrome	8.98e-05	0.000256	CcSEcCtD
Dipyridamole—Hypotension—Gabapentin—epilepsy syndrome	8.92e-05	0.000255	CcSEcCtD
Dipyridamole—Nausea—Carbamazepine—epilepsy syndrome	8.91e-05	0.000255	CcSEcCtD
Dipyridamole—Pain—Pregabalin—epilepsy syndrome	8.9e-05	0.000254	CcSEcCtD
Dipyridamole—Malaise—Topiramate—epilepsy syndrome	8.87e-05	0.000254	CcSEcCtD
Dipyridamole—Vertigo—Topiramate—epilepsy syndrome	8.84e-05	0.000253	CcSEcCtD
Dipyridamole—Syncope—Topiramate—epilepsy syndrome	8.82e-05	0.000252	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	8.7e-05	0.000249	CcSEcCtD
Dipyridamole—Palpitations—Topiramate—epilepsy syndrome	8.7e-05	0.000249	CcSEcCtD
Dipyridamole—Loss of consciousness—Topiramate—epilepsy syndrome	8.65e-05	0.000247	CcSEcCtD
Dipyridamole—Nausea—Lamotrigine—epilepsy syndrome	8.61e-05	0.000246	CcSEcCtD
Dipyridamole—Cough—Topiramate—epilepsy syndrome	8.59e-05	0.000245	CcSEcCtD
Dipyridamole—Feeling abnormal—Pregabalin—epilepsy syndrome	8.58e-05	0.000245	CcSEcCtD
Dipyridamole—Paraesthesia—Gabapentin—epilepsy syndrome	8.57e-05	0.000245	CcSEcCtD
Dipyridamole—Convulsion—Topiramate—epilepsy syndrome	8.53e-05	0.000244	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Pregabalin—epilepsy syndrome	8.51e-05	0.000243	CcSEcCtD
Dipyridamole—Dyspnoea—Gabapentin—epilepsy syndrome	8.51e-05	0.000243	CcSEcCtD
Dipyridamole—ABCB1—brain—epilepsy syndrome	8.5e-05	0.000552	CbGeAlD
Dipyridamole—Hypertension—Topiramate—epilepsy syndrome	8.5e-05	0.000243	CcSEcCtD
Dipyridamole—Somnolence—Gabapentin—epilepsy syndrome	8.49e-05	0.000243	CcSEcCtD
Dipyridamole—Hypersensitivity—Valproic Acid—epilepsy syndrome	8.48e-05	0.000242	CcSEcCtD
Dipyridamole—Dyspepsia—Gabapentin—epilepsy syndrome	8.4e-05	0.00024	CcSEcCtD
Dipyridamole—Arthralgia—Topiramate—epilepsy syndrome	8.38e-05	0.000239	CcSEcCtD
Dipyridamole—Chest pain—Topiramate—epilepsy syndrome	8.38e-05	0.000239	CcSEcCtD
Dipyridamole—Myalgia—Topiramate—epilepsy syndrome	8.38e-05	0.000239	CcSEcCtD
Dipyridamole—Anxiety—Topiramate—epilepsy syndrome	8.35e-05	0.000239	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	8.32e-05	0.000238	CcSEcCtD
Dipyridamole—Discomfort—Topiramate—epilepsy syndrome	8.28e-05	0.000237	CcSEcCtD
Dipyridamole—Urticaria—Pregabalin—epilepsy syndrome	8.27e-05	0.000236	CcSEcCtD
Dipyridamole—Asthenia—Valproic Acid—epilepsy syndrome	8.26e-05	0.000236	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	8.24e-05	0.000236	CcSEcCtD
Dipyridamole—Fatigue—Gabapentin—epilepsy syndrome	8.23e-05	0.000235	CcSEcCtD
Dipyridamole—Abdominal pain—Pregabalin—epilepsy syndrome	8.23e-05	0.000235	CcSEcCtD
Dipyridamole—Dry mouth—Topiramate—epilepsy syndrome	8.19e-05	0.000234	CcSEcCtD
Dipyridamole—Pain—Gabapentin—epilepsy syndrome	8.16e-05	0.000233	CcSEcCtD
Dipyridamole—Pruritus—Valproic Acid—epilepsy syndrome	8.15e-05	0.000233	CcSEcCtD
Dipyridamole—Oedema—Topiramate—epilepsy syndrome	8.03e-05	0.000229	CcSEcCtD
Dipyridamole—Shock—Topiramate—epilepsy syndrome	7.9e-05	0.000226	CcSEcCtD
Dipyridamole—Diarrhoea—Valproic Acid—epilepsy syndrome	7.88e-05	0.000225	CcSEcCtD
Dipyridamole—Nervous system disorder—Topiramate—epilepsy syndrome	7.88e-05	0.000225	CcSEcCtD
Dipyridamole—Feeling abnormal—Gabapentin—epilepsy syndrome	7.87e-05	0.000225	CcSEcCtD
Dipyridamole—Thrombocytopenia—Topiramate—epilepsy syndrome	7.86e-05	0.000225	CcSEcCtD
Dipyridamole—Tachycardia—Topiramate—epilepsy syndrome	7.84e-05	0.000224	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Gabapentin—epilepsy syndrome	7.81e-05	0.000223	CcSEcCtD
Dipyridamole—Skin disorder—Topiramate—epilepsy syndrome	7.8e-05	0.000223	CcSEcCtD
Dipyridamole—Hyperhidrosis—Topiramate—epilepsy syndrome	7.76e-05	0.000222	CcSEcCtD
Dipyridamole—Hypersensitivity—Pregabalin—epilepsy syndrome	7.67e-05	0.000219	CcSEcCtD
Dipyridamole—Dizziness—Valproic Acid—epilepsy syndrome	7.61e-05	0.000218	CcSEcCtD
Dipyridamole—Urticaria—Gabapentin—epilepsy syndrome	7.58e-05	0.000217	CcSEcCtD
Dipyridamole—Abdominal pain—Gabapentin—epilepsy syndrome	7.55e-05	0.000216	CcSEcCtD
Dipyridamole—Hypotension—Topiramate—epilepsy syndrome	7.5e-05	0.000214	CcSEcCtD
Dipyridamole—Asthenia—Pregabalin—epilepsy syndrome	7.47e-05	0.000213	CcSEcCtD
Dipyridamole—Pruritus—Pregabalin—epilepsy syndrome	7.37e-05	0.00021	CcSEcCtD
Dipyridamole—Vomiting—Valproic Acid—epilepsy syndrome	7.32e-05	0.000209	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	7.32e-05	0.000209	CcSEcCtD
Dipyridamole—Rash—Valproic Acid—epilepsy syndrome	7.26e-05	0.000207	CcSEcCtD
Dipyridamole—Dermatitis—Valproic Acid—epilepsy syndrome	7.25e-05	0.000207	CcSEcCtD
Dipyridamole—Headache—Valproic Acid—epilepsy syndrome	7.21e-05	0.000206	CcSEcCtD
Dipyridamole—Paraesthesia—Topiramate—epilepsy syndrome	7.21e-05	0.000206	CcSEcCtD
Dipyridamole—Dyspnoea—Topiramate—epilepsy syndrome	7.16e-05	0.000205	CcSEcCtD
Dipyridamole—Somnolence—Topiramate—epilepsy syndrome	7.14e-05	0.000204	CcSEcCtD
Dipyridamole—Diarrhoea—Pregabalin—epilepsy syndrome	7.12e-05	0.000204	CcSEcCtD
Dipyridamole—Dyspepsia—Topiramate—epilepsy syndrome	7.07e-05	0.000202	CcSEcCtD
Dipyridamole—Hypersensitivity—Gabapentin—epilepsy syndrome	7.03e-05	0.000201	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Topiramate—epilepsy syndrome	6.93e-05	0.000198	CcSEcCtD
Dipyridamole—Fatigue—Topiramate—epilepsy syndrome	6.92e-05	0.000198	CcSEcCtD
Dipyridamole—Dizziness—Pregabalin—epilepsy syndrome	6.88e-05	0.000197	CcSEcCtD
Dipyridamole—Pain—Topiramate—epilepsy syndrome	6.87e-05	0.000196	CcSEcCtD
Dipyridamole—Asthenia—Gabapentin—epilepsy syndrome	6.85e-05	0.000196	CcSEcCtD
Dipyridamole—Nausea—Valproic Acid—epilepsy syndrome	6.84e-05	0.000195	CcSEcCtD
Dipyridamole—Pruritus—Gabapentin—epilepsy syndrome	6.75e-05	0.000193	CcSEcCtD
Dipyridamole—Vomiting—Pregabalin—epilepsy syndrome	6.62e-05	0.000189	CcSEcCtD
Dipyridamole—Feeling abnormal—Topiramate—epilepsy syndrome	6.62e-05	0.000189	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Topiramate—epilepsy syndrome	6.57e-05	0.000188	CcSEcCtD
Dipyridamole—Rash—Pregabalin—epilepsy syndrome	6.56e-05	0.000188	CcSEcCtD
Dipyridamole—Dermatitis—Pregabalin—epilepsy syndrome	6.56e-05	0.000187	CcSEcCtD
Dipyridamole—Diarrhoea—Gabapentin—epilepsy syndrome	6.53e-05	0.000187	CcSEcCtD
Dipyridamole—Headache—Pregabalin—epilepsy syndrome	6.52e-05	0.000186	CcSEcCtD
Dipyridamole—Urticaria—Topiramate—epilepsy syndrome	6.38e-05	0.000182	CcSEcCtD
Dipyridamole—Abdominal pain—Topiramate—epilepsy syndrome	6.35e-05	0.000181	CcSEcCtD
Dipyridamole—Dizziness—Gabapentin—epilepsy syndrome	6.31e-05	0.00018	CcSEcCtD
Dipyridamole—Nausea—Pregabalin—epilepsy syndrome	6.18e-05	0.000177	CcSEcCtD
Dipyridamole—Vomiting—Gabapentin—epilepsy syndrome	6.07e-05	0.000173	CcSEcCtD
Dipyridamole—Rash—Gabapentin—epilepsy syndrome	6.02e-05	0.000172	CcSEcCtD
Dipyridamole—Dermatitis—Gabapentin—epilepsy syndrome	6.01e-05	0.000172	CcSEcCtD
Dipyridamole—Headache—Gabapentin—epilepsy syndrome	5.98e-05	0.000171	CcSEcCtD
Dipyridamole—Hypersensitivity—Topiramate—epilepsy syndrome	5.92e-05	0.000169	CcSEcCtD
Dipyridamole—Asthenia—Topiramate—epilepsy syndrome	5.76e-05	0.000165	CcSEcCtD
Dipyridamole—Pruritus—Topiramate—epilepsy syndrome	5.68e-05	0.000162	CcSEcCtD
Dipyridamole—Nausea—Gabapentin—epilepsy syndrome	5.67e-05	0.000162	CcSEcCtD
Dipyridamole—Diarrhoea—Topiramate—epilepsy syndrome	5.49e-05	0.000157	CcSEcCtD
Dipyridamole—Dizziness—Topiramate—epilepsy syndrome	5.31e-05	0.000152	CcSEcCtD
Dipyridamole—Vomiting—Topiramate—epilepsy syndrome	5.11e-05	0.000146	CcSEcCtD
Dipyridamole—Rash—Topiramate—epilepsy syndrome	5.06e-05	0.000145	CcSEcCtD
Dipyridamole—Dermatitis—Topiramate—epilepsy syndrome	5.06e-05	0.000145	CcSEcCtD
Dipyridamole—Headache—Topiramate—epilepsy syndrome	5.03e-05	0.000144	CcSEcCtD
Dipyridamole—Nausea—Topiramate—epilepsy syndrome	4.77e-05	0.000136	CcSEcCtD
Dipyridamole—PDE7A—Signaling Pathways—MMP9—epilepsy syndrome	7.42e-06	2.88e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—YWHAZ—epilepsy syndrome	7.41e-06	2.88e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	7.39e-06	2.87e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—SRC—epilepsy syndrome	7.36e-06	2.86e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CCR5—epilepsy syndrome	7.33e-06	2.85e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—NGF—epilepsy syndrome	7.33e-06	2.85e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—APOE—epilepsy syndrome	7.3e-06	2.83e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—CASP3—epilepsy syndrome	7.28e-06	2.83e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TSC2—epilepsy syndrome	7.28e-06	2.83e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—AGT—epilepsy syndrome	7.27e-06	2.82e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CASP8—epilepsy syndrome	7.25e-06	2.82e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—FYN—epilepsy syndrome	7.25e-06	2.82e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—AKT1—epilepsy syndrome	7.24e-06	2.81e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—H2AFX—epilepsy syndrome	7.23e-06	2.81e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—AVP—epilepsy syndrome	7.21e-06	2.8e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MEF2C—epilepsy syndrome	7.21e-06	2.8e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—AKT1—epilepsy syndrome	7.2e-06	2.8e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—AKT1—epilepsy syndrome	7.2e-06	2.8e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ASAH1—epilepsy syndrome	7.2e-06	2.79e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—CASP3—epilepsy syndrome	7.19e-06	2.79e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—HTR2A—epilepsy syndrome	7.17e-06	2.79e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—VEGFA—epilepsy syndrome	7.17e-06	2.78e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—FGF2—epilepsy syndrome	7.17e-06	2.78e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CCR5—epilepsy syndrome	7.13e-06	2.77e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—APOE—epilepsy syndrome	7.12e-06	2.77e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	7.12e-06	2.76e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—JUN—epilepsy syndrome	7.07e-06	2.75e-05	CbGpPWpGaD
Dipyridamole—PDE10A—GPCR downstream signaling—AKT1—epilepsy syndrome	7.07e-06	2.74e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—STXBP1—epilepsy syndrome	7e-06	2.72e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—CASP3—epilepsy syndrome	7e-06	2.72e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—HTR2A—epilepsy syndrome	6.98e-06	2.71e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—JUN—epilepsy syndrome	6.98e-06	2.71e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—KDR—epilepsy syndrome	6.98e-06	2.71e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—YWHAZ—epilepsy syndrome	6.97e-06	2.71e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—SRC—epilepsy syndrome	6.91e-06	2.68e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—NGF—epilepsy syndrome	6.89e-06	2.68e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—MMP9—epilepsy syndrome	6.88e-06	2.67e-05	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—PTGS2—epilepsy syndrome	6.88e-06	2.67e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	6.86e-06	2.66e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—SRC—epilepsy syndrome	6.84e-06	2.66e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—SRC—epilepsy syndrome	6.84e-06	2.66e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ALAD—epilepsy syndrome	6.82e-06	2.65e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NT5E—epilepsy syndrome	6.82e-06	2.65e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—HES1—epilepsy syndrome	6.82e-06	2.65e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TSC2—epilepsy syndrome	6.82e-06	2.65e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—AGT—epilepsy syndrome	6.81e-06	2.64e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—BCL2—epilepsy syndrome	6.81e-06	2.64e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—JUN—epilepsy syndrome	6.8e-06	2.64e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—MMP9—epilepsy syndrome	6.79e-06	2.64e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	6.79e-06	2.64e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—VEGFA—epilepsy syndrome	6.73e-06	2.61e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—PRKCB—epilepsy syndrome	6.72e-06	2.61e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CCR5—epilepsy syndrome	6.71e-06	2.6e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL6ST—epilepsy syndrome	6.69e-06	2.6e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—AKT1—epilepsy syndrome	6.68e-06	2.59e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—APOE—epilepsy syndrome	6.67e-06	2.59e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—VEGFA—epilepsy syndrome	6.67e-06	2.59e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—VEGFA—epilepsy syndrome	6.67e-06	2.59e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	6.66e-06	2.59e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—RELA—epilepsy syndrome	6.65e-06	2.58e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—FYN—epilepsy syndrome	6.63e-06	2.57e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TSC2—epilepsy syndrome	6.63e-06	2.57e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—AGT—epilepsy syndrome	6.62e-06	2.57e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—FGF2—epilepsy syndrome	6.62e-06	2.57e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—FGF2—epilepsy syndrome	6.62e-06	2.57e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—MMP9—epilepsy syndrome	6.62e-06	2.57e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—H2AFX—epilepsy syndrome	6.61e-06	2.57e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MEF2C—epilepsy syndrome	6.6e-06	2.56e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—AKT1—epilepsy syndrome	6.59e-06	2.56e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—HTR2A—epilepsy syndrome	6.56e-06	2.55e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—FGF2—epilepsy syndrome	6.56e-06	2.55e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—KDR—epilepsy syndrome	6.53e-06	2.54e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—MTOR—epilepsy syndrome	6.52e-06	2.53e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	6.51e-06	2.53e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	6.51e-06	2.53e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—APOE—epilepsy syndrome	6.49e-06	2.52e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—AKT1—epilepsy syndrome	6.42e-06	2.49e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—YWHAZ—epilepsy syndrome	6.38e-06	2.48e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	6.37e-06	2.47e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—KDR—epilepsy syndrome	6.36e-06	2.47e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—SRC—epilepsy syndrome	6.35e-06	2.46e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NGF—epilepsy syndrome	6.3e-06	2.45e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PRKCB—epilepsy syndrome	6.29e-06	2.44e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—POMC—epilepsy syndrome	6.27e-06	2.43e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL6ST—epilepsy syndrome	6.26e-06	2.43e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—SRC—epilepsy syndrome	6.26e-06	2.43e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ADSL—epilepsy syndrome	6.24e-06	2.42e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TSC2—epilepsy syndrome	6.23e-06	2.42e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—AGT—epilepsy syndrome	6.23e-06	2.42e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—BCL2—epilepsy syndrome	6.22e-06	2.42e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—AKT1—epilepsy syndrome	6.2e-06	2.41e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—VEGFA—epilepsy syndrome	6.18e-06	2.4e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCR5—epilepsy syndrome	6.13e-06	2.38e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GLUL—epilepsy syndrome	6.12e-06	2.38e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—POMC—epilepsy syndrome	6.12e-06	2.38e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PRKCB—epilepsy syndrome	6.12e-06	2.38e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—SRC—epilepsy syndrome	6.1e-06	2.37e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—APOE—epilepsy syndrome	6.1e-06	2.37e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—AKT1—epilepsy syndrome	6.1e-06	2.37e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—VEGFA—epilepsy syndrome	6.1e-06	2.37e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL6ST—epilepsy syndrome	6.09e-06	2.37e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—RELA—epilepsy syndrome	6.09e-06	2.36e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—FGF2—epilepsy syndrome	6.05e-06	2.35e-05	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—AKT1—epilepsy syndrome	6.04e-06	2.34e-05	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—AKT1—epilepsy syndrome	6.04e-06	2.34e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—MTOR—epilepsy syndrome	6.02e-06	2.34e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—MTOR—epilepsy syndrome	6.02e-06	2.34e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL1B—epilepsy syndrome	6.01e-06	2.34e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	6.01e-06	2.33e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—HTR2A—epilepsy syndrome	6e-06	2.33e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CCL2—epilepsy syndrome	5.99e-06	2.32e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—KDR—epilepsy syndrome	5.98e-06	2.32e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	5.97e-06	2.32e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—PTGS2—epilepsy syndrome	5.97e-06	2.32e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—PTGS2—epilepsy syndrome	5.97e-06	2.32e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—MTOR—epilepsy syndrome	5.97e-06	2.32e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—VEGFA—epilepsy syndrome	5.94e-06	2.31e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—JUN—epilepsy syndrome	5.83e-06	2.26e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	5.82e-06	2.26e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PRKCB—epilepsy syndrome	5.75e-06	2.23e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—POMC—epilepsy syndrome	5.73e-06	2.22e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL6ST—epilepsy syndrome	5.73e-06	2.22e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—ALB—epilepsy syndrome	5.71e-06	2.22e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TSC2—epilepsy syndrome	5.7e-06	2.21e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—AGT—epilepsy syndrome	5.69e-06	2.21e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—AKT1—epilepsy syndrome	5.67e-06	2.2e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—AKT1—epilepsy syndrome	5.63e-06	2.19e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	5.62e-06	2.18e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CCL2—epilepsy syndrome	5.61e-06	2.18e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	5.58e-06	2.17e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—APOE—epilepsy syndrome	5.58e-06	2.17e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—AKT1—epilepsy syndrome	5.58e-06	2.17e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—POMC—epilepsy syndrome	5.57e-06	2.16e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—AKT1—epilepsy syndrome	5.56e-06	2.16e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	5.53e-06	2.15e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—MTOR—epilepsy syndrome	5.51e-06	2.14e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL1B—epilepsy syndrome	5.5e-06	2.14e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—KDR—epilepsy syndrome	5.47e-06	2.12e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PTGS2—epilepsy syndrome	5.46e-06	2.12e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—AQP1—epilepsy syndrome	5.46e-06	2.12e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CCL2—epilepsy syndrome	5.45e-06	2.12e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—FGF2—epilepsy syndrome	5.41e-06	2.1e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—JUN—epilepsy syndrome	5.33e-06	2.07e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PRKCB—epilepsy syndrome	5.26e-06	2.04e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—POMC—epilepsy syndrome	5.24e-06	2.03e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL6ST—epilepsy syndrome	5.24e-06	2.03e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—SRC—epilepsy syndrome	5.23e-06	2.03e-05	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—AKT1—epilepsy syndrome	5.13e-06	1.99e-05	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—AKT1—epilepsy syndrome	5.13e-06	1.99e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CCL2—epilepsy syndrome	5.13e-06	1.99e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—AKT1—epilepsy syndrome	5.1e-06	1.98e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—FGF2—epilepsy syndrome	5.07e-06	1.97e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—RELA—epilepsy syndrome	5.02e-06	1.95e-05	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—AKT1—epilepsy syndrome	5e-06	1.94e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PTGS2—epilepsy syndrome	5e-06	1.94e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	4.99e-06	1.94e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CHRM3—epilepsy syndrome	4.93e-06	1.92e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	4.93e-06	1.92e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—FGF2—epilepsy syndrome	4.93e-06	1.91e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MTOR—epilepsy syndrome	4.93e-06	1.91e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—SRC—epilepsy syndrome	4.83e-06	1.87e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—SRC—epilepsy syndrome	4.83e-06	1.87e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—POMC—epilepsy syndrome	4.79e-06	1.86e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—SRC—epilepsy syndrome	4.78e-06	1.86e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—RELA—epilepsy syndrome	4.7e-06	1.83e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCL2—epilepsy syndrome	4.69e-06	1.82e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—FGF2—epilepsy syndrome	4.63e-06	1.8e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MTOR—epilepsy syndrome	4.61e-06	1.79e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—RELA—epilepsy syndrome	4.58e-06	1.78e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—AKT1—epilepsy syndrome	4.58e-06	1.78e-05	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—AKT1—epilepsy syndrome	4.57e-06	1.78e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CASP3—epilepsy syndrome	4.53e-06	1.76e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MTOR—epilepsy syndrome	4.49e-06	1.74e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—SRC—epilepsy syndrome	4.42e-06	1.71e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—JUN—epilepsy syndrome	4.4e-06	1.71e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—RELA—epilepsy syndrome	4.3e-06	1.67e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—AKT1—epilepsy syndrome	4.3e-06	1.67e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MMP9—epilepsy syndrome	4.28e-06	1.66e-05	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—AKT1—epilepsy syndrome	4.28e-06	1.66e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—AKT1—epilepsy syndrome	4.25e-06	1.65e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—AKT1—epilepsy syndrome	4.25e-06	1.65e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CASP3—epilepsy syndrome	4.24e-06	1.65e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—FGF2—epilepsy syndrome	4.24e-06	1.65e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MTOR—epilepsy syndrome	4.22e-06	1.64e-05	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—AKT1—epilepsy syndrome	4.17e-06	1.62e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—AKT1—epilepsy syndrome	4.15e-06	1.61e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CASP3—epilepsy syndrome	4.13e-06	1.6e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—JUN—epilepsy syndrome	4.12e-06	1.6e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ABCG2—epilepsy syndrome	4.02e-06	1.56e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MMP9—epilepsy syndrome	4.01e-06	1.56e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—JUN—epilepsy syndrome	4.01e-06	1.56e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—SRC—epilepsy syndrome	3.95e-06	1.53e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—AKT1—epilepsy syndrome	3.94e-06	1.53e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—RELA—epilepsy syndrome	3.93e-06	1.53e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	3.92e-06	1.52e-05	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.92e-06	1.52e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MMP9—epilepsy syndrome	3.9e-06	1.51e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	3.9e-06	1.51e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—AKT1—epilepsy syndrome	3.89e-06	1.51e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—AKT1—epilepsy syndrome	3.89e-06	1.51e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CASP3—epilepsy syndrome	3.88e-06	1.51e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MTOR—epilepsy syndrome	3.86e-06	1.5e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—VEGFA—epilepsy syndrome	3.84e-06	1.49e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—AKT1—epilepsy syndrome	3.79e-06	1.47e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—AKT1—epilepsy syndrome	3.78e-06	1.47e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—JUN—epilepsy syndrome	3.77e-06	1.46e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	3.71e-06	1.44e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—SRC—epilepsy syndrome	3.7e-06	1.43e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MMP9—epilepsy syndrome	3.67e-06	1.42e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—VEGFA—epilepsy syndrome	3.6e-06	1.4e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—SRC—epilepsy syndrome	3.6e-06	1.4e-05	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—AKT1—epilepsy syndrome	3.58e-06	1.39e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—AKT1—epilepsy syndrome	3.56e-06	1.38e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CASP3—epilepsy syndrome	3.55e-06	1.38e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	3.52e-06	1.36e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—VEGFA—epilepsy syndrome	3.5e-06	1.36e-05	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—AKT1—epilepsy syndrome	3.46e-06	1.34e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—JUN—epilepsy syndrome	3.45e-06	1.34e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—SRC—epilepsy syndrome	3.38e-06	1.31e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MMP9—epilepsy syndrome	3.35e-06	1.3e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.35e-06	1.3e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	3.35e-06	1.3e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—BCHE—epilepsy syndrome	3.33e-06	1.29e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—VEGFA—epilepsy syndrome	3.29e-06	1.28e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—AKT1—epilepsy syndrome	3.25e-06	1.26e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—AKT1—epilepsy syndrome	3.25e-06	1.26e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	3.18e-06	1.23e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PLCB1—epilepsy syndrome	3.14e-06	1.22e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—TH—epilepsy syndrome	3.13e-06	1.22e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—SRC—epilepsy syndrome	3.09e-06	1.2e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—VEGFA—epilepsy syndrome	3.01e-06	1.17e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—AKT1—epilepsy syndrome	3e-06	1.16e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—AKT1—epilepsy syndrome	3e-06	1.16e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—AKT1—epilepsy syndrome	2.97e-06	1.15e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—AKT1—epilepsy syndrome	2.74e-06	1.07e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—HMOX1—epilepsy syndrome	2.62e-06	1.02e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CAT—epilepsy syndrome	2.58e-06	1e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—AKT1—epilepsy syndrome	2.51e-06	9.75e-06	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—AKT1—epilepsy syndrome	2.45e-06	9.52e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GPX1—epilepsy syndrome	2.33e-06	9.06e-06	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—AKT1—epilepsy syndrome	2.3e-06	8.92e-06	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—AKT1—epilepsy syndrome	2.23e-06	8.67e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—AKT1—epilepsy syndrome	2.1e-06	8.16e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—AGT—epilepsy syndrome	2.05e-06	7.94e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—APOE—epilepsy syndrome	2e-06	7.78e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—AKT1—epilepsy syndrome	1.92e-06	7.46e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—POMC—epilepsy syndrome	1.72e-06	6.69e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ALB—epilepsy syndrome	1.57e-06	6.1e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.37e-06	5.33e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—AKT1—epilepsy syndrome	6.9e-07	2.68e-06	CbGpPWpGaD
